Reddit Posts
Made some okay investments - Thought someone may be interested?
Trading pharmaceutical stock options around FDA announcements (drug approval/rejection)
FDA to back accelerated approval pathway for gene therapies (NASDAQ:SRPT)
Hot Stocks: XPEV rises on earnings; MARA, MSTR, RIOT boosted by BTC price; FRC, SRPT slide
Hot Stocks: TUP, ANF slump on financial figures; DUOL surges; SRPT climbs on FDA decision
$REV - Hey morons, tired of the fucking trust me bro squeeze ? Check thats's sexy DD !
$REV - Hey morons, tired of the trust me bro squeeze ? Check thats's sexy DD !
Three Biotech Stocks That Could Rise 90% or More, According to Motley Fool
Will AGC see SRPT like rip Monday if they drop merger date in PM?
3 Biotech Stocks That Could Rise 90% or More, According to Wall Street Experts, per Motley Fool
Congrats to all those who stuck with Golden Nugget / Portfolio update
Congrats to all those who stuck with GNOG / Portfolio update
CALLING ALL APES!!!! $SRPT Time to jump in this is going to be big lets make it as big as $GME.
$SRPT this stock is set to squeeze up 26% so far today time to jump in.
Actionable Trading MRNA SRPT CRSP GSK PFE MODERNA HITS $100 Billion GENE RNA MED
Mentions
Wow. SRPT is down hard. Shkreli likes it at this price. What's our take?
I almost bought 100 shares of SRPT today at 50. its 36.50 AH. birb, idk what im doing. 🤣
How do you even go on an earnings call after your stock just had a -25% hit during market hours, and another -25% hit after your earnings release (SRPT)? Lmao
SRPT was down 26% during the day and 19% more after hours 💀
imagine being the SRPT YOLO guy right now
SRPT 💪 Earnings tonight. 
Just got liquidated on my SRPT long. Fck this never trading again!
*Hmmmm......SRPT reports after hours and drops 23% today? Maybe somebody knows something.* 
So apparently, the shares of many vaccine makers, including Moderna ([MRNA](https://www.tipranks.com/stocks/mrna)), Novavax ([NVAX](https://www.tipranks.com/stocks/nvax)), and BioNTech ([BNTX](https://www.tipranks.com/stocks/bntx)) (BTNX), and gene therapy developers, including Sarepta ([SRPT](https://www.tipranks.com/stocks/srpt)), Solid Biosciences ([SLDB](https://www.tipranks.com/stocks/sldb)), Taysha Gene Therapies ([TSHA](https://www.tipranks.com/stocks/tsha)), Capricor Therapeutics ([CAPR](https://www.tipranks.com/stocks/capr)), and Crispr Therapeutics ([CRSP](https://www.tipranks.com/stocks/crsp)), are moving lower following the resignation of Peter Marks from the Food and Drug Administration. Marks was viewed as one of the biggest FDA advocates of cell and gene therapies. [Vaccine, gene therapy makers fall after Peter Marks resignation - TipRanks.com](https://www.tipranks.com/news/the-fly/vaccine-gene-therapy-makers-fall-after-peter-marks-resignation)
Despite the bumpiness im breaking even today. Starting to rotate into ex-US and Healthcare. Been eyeing SRPT given its low forward P/E and potential tailwinds, although it had a slight earnings miss.
Im gonna post my plays from yestarday 1 TKO put 2 SUI puts 1 SRPT put All at the money for 3/21 and I added 50 more PBA calls just for good luck
I have basically clawed back all of my losses from the other day, and I am back to outperfoming the S&P YTD. Buying Vistra on the dip proved to be fruitful and I've just closed out my swing trade on TSM. Thinking I'll close out on ANET tomorrow. That said, what looks cheap in this market? I decided to sector rotate a bit into healthcare since it got punished to start the year. ABBV earnings are tomorrow, LLY on Feb 6, PFE on Feb 4, and SRPT on Feb 26. Bought PFE and SRPT as they are both trading at <10x Forward.
Any wallstreetdoctors in SRPT or AWRW
SRPT was the ticker de jour when I was a mod.
lots of bios popping because SRPT news?
SRPT printed for Mike Taylor, genius healthcare fund manager over at simplify ETFs. highly recommend [https://finance.yahoo.com/quote/PINK/holdings/](https://finance.yahoo.com/quote/PINK/holdings/)
$SRPT June 28 $160 puts 🚨
WTF happened with SRPT, I was thinking of buying calls today
SRPT It’s just starting… 
the guy who runs this is a genius (way early on GLP1, e.g.), and his current holdings are pretty contrarian imo: [https://finance.yahoo.com/quote/PINK/holdings/](https://finance.yahoo.com/quote/PINK/holdings/) SRPT JNJ (just finished up Talc lawsuits, ) MMM (just hired a great CEO and is doing spin outs to focus on core competencies, ) interview with the guy: [https://www.youtube.com/watch?v=hLbVfHMe8Fk](https://www.youtube.com/watch?v=hLbVfHMe8Fk)
Does anyone know why SRPT is tanking?
SRPT going on a run straight vertical today
$SRPT. Bought it at $12 when it was waiting for approval by the FDA. Held it till it jumped to $28. Sold half and watched it jump to $40. But There was a snow storm the week of approval and the FDA shut down and rescheduled approval. It slowly fell. Down past $10. Thought… I’ll sell and if it drops to $7 I’ll start buying again. But I got busy and forgot. At one point I’d actually held 6,000 shares. But I sold them all as it dropped. After approval? It jumped to $160. Yeah. Yeah. I also sold Apple at like $12? Back in 2004?
SRPT. Down on an overreaction, likely getting gene therapy fully FDA approved.
Why are you invested in a gene therapy biotech? 😂 You probably should dump SRPT since you happened to catch a temporary rebound in its soap opera-like storyline. The company’s drugs don’t actually benefit patients. Take your $ and run
ABNB put, PYPL call, ETSY call, Z put, ROKU put, SRPT call. Where is it all gonna go wrong..
Whoever has the 1793 11/3 70p's on SRPT, can we talk?
buy SRPT calls that expire end of november - strike 185 ;)
Fuck it. Go pharma all or nothing. I got you https://optionstrat.com/build/calendar-put-spread/SRPT/.SRPT231215P110,-.SRPT231117P110
$SRPT a biotech. It will either double or get cut in half in the next 2 months. 10% of my net worth is on the line. It will make or break my trading career.
Why is SRPT IV so fucking high over the historical? Like holy shit. Some big moves are going to be happening. Someone knows something
I recall Ritalin prodrugs being thought to be more effective than stereoisomers; the body of research wasnt going in this direction last I checked. With a trial and proper scrutiny, 1301 will be their starchild. But buspirone this decade...ugh. There's counterindications in a significant portion of adults presenting anxiety... The general move away from benzos and towards adjunct (+SSRI/MAOI) therapies has popularized it as a first or second line of treatment, but clinically, the existing incarnation doesn't play well with obesity and hypertension comorbidities - consider the target market is America. Since 2103 is a simpler delivery system, I'm not confident the proper pharmacokinetics will be altered to a satisfactory degree. Watch the trial info for 1301. If it's positive and precedes an earnings call, CING will be this year's KBIO/SRPT.
get into SRPT while you can.
Getting insane value out of SRPT. Boutta fingerPOP eachother assholes
Made a bad credit spread play but was ready to eat the loss. $40/$60 risk profile. Super small play, SRPT kept going lower after an fda approval, play gone awry. When the stock was $123, I sold the July 23 $123p and bought the $122 for shits and gigs. Now at $108.5. No biggie, I'll eat the $60 loss at expiration. Noooope. Just got assigned the 100 shares at $123. In my four years of trading, I've somehow never been assigned early on a credit spread. So thinkorswim is listing me down $1450 on shares, and only up $965 on the remaining put option. Down $485 as is. Can someone help me understand how this is such a wide p/l open loss as is right now? And how to I most effectively get the fuck out of this trade as close to my expected $60 loss? Do I just exercise my 122 bought put first thing in the morning?
Know how to trade more illiquid options and this isn’t a problem.. even lot of names that only have monthlies are super illiquid(lot of biotech) and you just have to know how to navigate a super wide bid/ask spread. If it’s a problem for you don’t trade them, sometimes I have to submit 6-7 bids and keep reducing my price by .05-10 every time to find the highest possible premium I can receive.. only do this when you want to own the name, not when your focus is simply trading as when you want to close the trade the wide spread/lack of liquidity can be terrible.. (I sell lot of biotech puts including names like SRPT, NBIX, HALO, ZLAB etc. Had to submit at least 4-5 bids to get filled on each of these as I don’t want to get ripped off).
Casual 30% on the SRPT smash and grab. Off to work. Done for today.
anyone know any upcoming caralyst for SRPT small batches of ask buying from end of May through Sept, 15%+ OTM
Seems like no one cares about $SRPT stock They just had earnings and only 0.03% change in price on 23,000 volume.
I read these every time you post them and I still don't understand how I take that data and turn it into action. I'm looking at the cheap puts. SRPT is at 131.9 right now. Can somebody please help fix my understanding? New-ish trying to make sense of how all the pieces fit. Stock - The stock, I got this down. Put IV - Looking at the stock price fluctuations over the next year, the Put IV is an estimate at the strength of which the stock might move. (A $100 stock with a put IV of 3 is expected to stay close to $100, but a Put IV of 75 is expected to be wildly different?) Direction - Not sure. Positive is bullish and negative is bearish? Is the amount the strength in that direction? That doesn't seem right to me because some of the #s contradict the Put IV then. Past Move +- - Total amount the stock has moved up and down over the last 4 weeks? If it goes up $10 today and down $5 tomorrow, would this show $15? Priced Down Move - Not sure on this one. Can't figure out how to apply it to all of my other guesses. RIVN for example says -44.14 but the stock is trading at 13.7. A year ago, it was at 50-ish. In both of those scenarios a move of that much seems off so I know I'm misunderstanding the data. Put premium - I get this one, too. So, taking all of my definitions.. uh, fuck man I don't know. I better go back to the drawing board and read some more. SRPT is at 131.9.
As **George Carlin** *tried* to warn you; "It's a club that *you* are *not* a member-of." The stock market is a scam*, designed* to take your money and ideas *away* from you. I *also* lost money on SRPT a couple of years ago when it was delisted, but hey, *look*, it's *back* again too! Why, it's even at a *higher* price than when I bought it. Of course, they took my money too. ***Crypto*** **is the** ***only*** **game in town where you** ***might*** **have a chance to be profitable. The thieving government** ***hates*** **that they have no control over it.**
We started with 50k and my shares are 250 AGI, 125 AMD, 646 CRBP, 538 FRC(yowch), 20 NVDA, and 100 SRPT.
Fire sale on SRPT today. FDA reversed decision to not have AdCom meeting. No new safety concerns on SRP-9001, and no delay on May 29 approval decision deadline. It is the only therapy with potential for significant improvement in QoL and even survival in a devastating disease. Not approving would be downright cruel to these patients, who have no effective therapies on the market. I’m mad about ur the delay, but happy for the discount.
SRPT is my best option trade since I started late last year. As a poor, I only could afford 2 contracts, but bought 2 160c @ 1.60. Just sold 1 to lock in 50% profit and am to ding the rest. I know the company, the gene therapy, and the clinical need. There is almost 0 chance FDA doesn’t approve. Only questions are a) when, and b) how much approval is already priced in.
SRPT any good with new BLA filing?
I was in a stock $IMMU that was diluted for 20+ years by the CEO and his wife. I bought it @ $3. They got bought out at $88. I'm in another one $SRPT, constant dilutions, I've never been more confident in an investment. That is the whole point of the capital markets in a sense. It's something to be aware of, but not the ultimate decider wether or to not own a company. To each their own though... but this is a hedge on my short Arkk position and the options have good premium, so it's working for me for now 🤷
>Dir Chambers Buys 57,100 Of Sarepta Therapeutics Inc $SRPT ^\*Walter ^Bloomberg ^[@DeItaone](http://twitter.com/DeItaone) ^at ^2022-09-15 ^08:06:23 ^EDT-0400
For real, It was ticker symbol SRPT. I bought 1000 shares in Oct 2008 for $3.25 and sold it in May 2020 for $146. I'm doing the same today with small cap stocks, just buying companies I like and holding for 5+ years. Here are a few VRM, WISH, Sofi, MQ, Vizio, PLTR, SDC. Some are memes today, but who cares. In 5 years, they'll either be bigger, or get bought. Both are win-wins.
Senti Biosciences ($SENTI) and Sarepta Therapeutics ($SRPT) are two biotechs that look like are going to have good days, according to the pre-market trading.
This play is literally what happened to SRPT, if something is too good to be true in the market , it probably is
How does SRPT go down 11% on good news? Glad I didn’t get options 🤡.
I'd use her advice with a grain of salt. Bought SRPT thinking she knew what she was doing. Almost a year later and I'm still down 15%. Did she not also buy into the famous company HOOD which uses PFOF? Her claim to fame is Tesla and she's been riding that ever since.
what happened for SRPT?
PROG is doing just what SRPT did. $4, $6, $9, $12, $18, $32 and then $60. Difference is that everyone held and bought so no shares where available to short. Again, you have to do whats best for you, but for me it's rent vs retirement money. I want retirement money
> Yes, I am still in. It is a good company with an excellent team and strong fundamentals. The stock price has been depressed for years as it was caught up in the general market selloff that began around 2014/2015 which saw many biotech stocks fall by 50% or more due to fears of FDA regulation changes (which never came) and also because investors were losing faith in the sector after several companies had failed clinical trials despite having promising drug candidates on their pipelines - this included big names like Juno Therapeutics ($JUNO), Zogenix ($ZGNX), Celladon Corp., Sarepta Therapeutics Inc.($SRPT).
taken from this mornings post on aussie hotcopper regarding ANP's deal with Sarepta SRPT: ​ Speculation around this forum is as to whether Sarepta have just raised $500mil to add to their treasure chest of $1.6bil in cash, to possibly partner up with ANP for a significant amount Now those that have been here a while have read my own thoughts on a deal and an eventual Sp of $19.00 ++ in possibly the next 6 years if you want to hang around that long and the ducks line up for ANP Wow some of you may say this guy is a nutter pie in the sky RAMPER SNAKE OIL SALESMAN LOL So lets just take a look where I am coming from, below you will see an extract taken from our August 2020 presentation from our own board as in Value creation Potential of Atl1102 for DMD Value Creation Potential of ATL1102 for DMD • Exondys 51 – first FDA approved treatment for DMD (2016) • Exondys 51 is only useful in 13% of boys with the exon 51 mutation. Vyondys 53, approved in 2019 for approx. 8% boys with exon 53 mutation. • Both received accelerated approval based on the surrogate endpoint of dystrophin increase in skeletal muscle observed in some treated patients • Sarepta market capitalisation has grown from \~US$60m (July 2012) to $3 billion on FDA approval of Exondys 51- today \~US$12 billion • Inflammation (the target of ATL1102 in DMD) contributes to disease progression in all DMD patients • Cost per patient of Exondys 51 is US$300K/year • 1st quarter 2020 total net revenue for Sarepta – US$100 million • Roche recently acquired EU rights from Sarepta for early stage gene therapy for DMD for US$1.15 billion upfront with US$1.7 billion in milestones plus royalties on sales Now the two points I want you to take on board are in the title Value Creation Potential of ATL1102 for DMD and the second The value of the recent deal with Roche again from the presentation Roche recently acquired EU rights from Sarepta for early stage gene therapy for DMD for US$1.15 billion upfront with US$1.7 billion in milestones plus royalties on sales YES You are reading this correct, Sarepta received US$1.5bil up front payment which consisted of US$750,000,000 in cash and US$400,000,000 in Equity Now this figure was for a deal for EARLY STAGE GENE THERAPY for the rights to the EU this was for a Ph2 trial with no Data as the trial was incomplete when the deal took place so it was basically a blind deal, And most on this forum now are aware of the end result basically the trial fell on its face HMM This Led to a drop in Sareptas MC basically over night going from $15bil down to a little over $7bil YES $7 – 8bil loss overnight more or less So why all the hype and fuss with ANP Well ANP have at this stage a successful phase 2 trial with outstanding results in both, physical and scientific data, in fact one of the leading Professors in the field of Dmd has said, these are results that have never, ever been seen before in these boys with this disease, with the reduction in fact fraction and basically stopped further muscle degeneration over the 6 month period, something you would never expect to have seen as you could almost guarantee increased fat and decreased muscle mass over the same period without treatment. Since this time we have backed up 1102 with further scientific data, which can and will be followed through in other indications, of which patents have now been registered for. So looking at all the above value creation potential, I am expecting Yes Expecting no less, I don't really care how the figures stack up so long as the end return is of similar value So yes we are sat at 31.5c today but you add a partnership to the tune of Roches deal which equated to US $2.85Billion inc milestones + ROYALTIES You tell me what we should be worth BUT NO WAIT there is more This would be for only 50% of the global rights for 1102 in boys with DMD So therefore if a deal is done for around that figure then one would have to take into account of our other Global 50% would carry initially a similar value equating to a further valuation of an extra $2.85Bil So if the partnership can be done to the same magnitude, and I see no reason why it shouldn't, we could be looking at adding an initial further $5.7bil in value in a parabolic way Then you look at a successful PH2 trial in RRMS awaiting funding to crossover into another unmet field in SPMS Then look at a successful PH2 trial in Acromegaly awaiting funding to advance Then up and coming further indications, that we have existing patents on, and the new indications patents applied for. You may begin to understand the excitement building here especially with Sareptas recent raising of $500mil @ market, just trying to join the dots and not the only one So if you have just jumped onboard here, as a day trader or looking short term, if the above pans out, this could well be your lucky day, think long and hard before you pull the trigger on those short term shares you have just acquired. Am I a SNAKE OIL SALESMAN just ask yourself Where did my information come from Couple of side notes whilst I am here u/mephistophles I had no problem with you divulging your holdings here, in-fact I admire you as a single mum trying to do what you are doing, and also the Rangies and lambos, just a bit of fun We are excited of course we are, are we not allowed to be without being classed as egotistical, That is the problem across and throughout Australia at this moment in time the FUN POLICE ARE EVERYWHERE some folks should lighten up and enjoy
I bought with shares and I think I'll be very safe. I'm not buying calls on it though. I've tried calls on big drops this year (TDOC and SRPT), and I lost almost all my money on those calls
you had SRPT too? I was buying calls on Kathy picks at the start of the year. A lot of them died hard deaths
You know what sucks. when your underlying stock is doing great, going up for weeks, then suddenly the company does a stock offering out of nowhere, and your calls lose 50% of value. Thx SRPT, bitch
"if i sold my SRPT Jan 22 call a week ago before the surprise stock offering, I would have $800 instead of $285." This type of brutality has been happening to my calls, this year especially
I bought $SRPT when it was $12- but it was a nighmare with all the up and down. Remember $SRPT at $150. Not sure if i will see that again. Sometime it makes sense to be long term investors but when you get hit with these roundtrips - you wonder if trading is better!!!
what are stocks that are still at March lows? * T * VZ * SRPT
added $OTLC for the pending news with JV and Parkinson drug reduced $SESN the news from EMA is about the same FDA- making it more likely that they will have to repeat the clinical trial added $SRPT- looks to go back to its high
Not saying this is going to short squeeze but I don’t think you’re correct in your line of thinking. 20% of the volume is me alone today so no….it’s not short sellers covering. Between my orders, r/SPACs buying in smaller lots, and other buyers from the S3 Partners tweet referenced in SPAC-eys above post which probably brought more buyers than this sub brought, that’s probably collectively ~50% of the buying volume today. As concerns arbitrage hedge funds selling into any bids: There’s only 20 million shares that need to get flipped, assuming every single share is owned by an fund which I clearly isn’t the case since large lots are being acquired today and presumably before that too, given the stock uptrend the past week or so . If there is interesting price momentum associated with either more retail buyers piling in before the merger, or some short sellers covering before the merger, that catches the attention of momentum traders, and the daily volume could potentially become multiples of current daily volume. What’s the point? The arbitrage hedge funds will be able to easily offload their shares in one fell swoop because of high volume. Look at any of the recent trash “squeeze” stocks such as BBIG, SRPT, etc. and their daily volumes. “Arbs” flipping their shares are only an issue for price suppression when there aren’t any buyers or relatively few buyers, as has been the case with SPACs since the bubble popped. If there is good buying volume, then arbitrage funds aren’t an issue.
Dang, you got me excited for a second. I have SRPT
why did my dumb ass not know about SRPT /cry
I think a lot of pharma is undervalued rn. SRPT and HOOK are the two I’ve picked up recently.
SRPT. They missed on a drug, but the rest of their pipeline is solid and I think they bounce back.
I considered buying into SRPT when it dropped 50%. It's not a penny stock but similar situation. It raised slightly then went lower. You can buy in but be prepared for a very long wait to crawl back up.
All the stupid morons jumping up and down because MRNA 🔪ran up like a chimp up a tree, you dumb fucks BNTX reported earnings and it 🚀🚀🚀. IMHO Moderna is shady af, they got lucky by stumbling [may have been given it by a 3 letter agency] on to the right sequence and the vaccine worked, it was up there with the likes of FWP, FOLD, ICPT, SRPT and other boiler room pump and dump trash.
SRPT missed both earnings and revenue, up 17% lololol
You mean SRPT
Is an insidiously dangerous subreddit masquerading as memes and camaraderie. A post COVID casino that facilitates much more loss than gain. As you know, convicted felon Martin Shkreli used to be a mod here, and his crime was duping investors, his predicted “better than any other index” gene therapy ETF of $SGMO, $PTCT, $SIOX, $SRPT etc..has plummeted while denouncing CRSP, INTL and EDIT which went on to win a Nobel prize and subsequently “mooned”. Did WSB do a good thing to MELVIN? Sure, but that’s where it ends. You know who’s not insidious? buffet. You don’t need risk to make money. If you would have put it all in BRK.B/BRK.A in may 2020 you’d have been more than fine, but instead the tantalizing memes leads to big unnecessary loss. Please open the gun filled Smokey halls of Las Vegas again so you know for sure you’re getting screwed. The evolution of who can screw over who the most creatively.
What are you even talking about? Their front page is literally a picture of a person with a headset and scroll down text talking about their history, services, and being a remote service. Are you sure you went to the right website? lol Remember it’s $SPRT, not $SRPT.
Had $ATOS, had a $4.06 average. My loss stop kicked in and came out with some small gains. I’m currently looking at $SRPT and $UONE. Let’s hope this week is great with $UONE.
Also if you put in $SRPT (even though it’s no penny) I also believe that’s going to run soon. It’s been slowly gaining for 2 weeks.
Look at the charts, literally every stock and crypto is dumping hard this morning, the only ones on my tracker that aren't are SPY, AMD, and SRPT. It's just a blood red day, has nothing to do with specific stocks or their performance.
CEO Doug Ingram is not universally disliked. He is universally appreciated to be one of the best biotech CEO’s. Patient advocates and patients praise Sarepta. Two more Sarepta DMD drugs have received FDA approval since Exondys in 2016. SRPT has 40 potential drugs in it’s pipeline, from preclinical through Phase III trials. PPMO and gene micro dystrophin will be game changers for the industry.
Looking at SRPT and xrp as always. SRPT has recovered w good news since it’s huge decline and xrp still has the sec case going on, what r h guys looking at
SRPT QND XRPemote:free\_emotes\_pack:flip\_out
A few hard lessons learned: Understand the Greeks. $SRPT was meeting with the FDA for drug approval and there was a ton of volatility in the options pricing. The screener suggested doing a debit put spread (aka put vertical) but I thought I knew better and bought call options. The FDA rescheduled the meeting and all the volatility fizzled out, the stock didn't move and I lost about 2 grand. Sell volatility when it's high. $BB released a new phone, they were $RIM at the time, and the stock popped. I figured the pop wasn't going to be long lived so I loaded up on put options. The stock kept rising and my puts expired worthless. Speculation can get expensive. I did a straddle on $ARII, which since merged, right before earnings. The move wasn't enough to cover the straddle. Make sure the moves are enough to cover both sides of the straddle. Yesterday I closed a put vertical on $AMC (12.5/11) that expired Friday...had I rode it out, I would have probably taken a loss since the stock took a dive. Don't get greedy - take your profit and move on. I usually take a 50-75 percent profit. Options are also decaying assets so time (theta) can be your enemy. https://www.optionsplaybook.com/ is a good resource.
SRPT +13%. Months ago it dropped about 50%
SRPT up 12% because they shared the news of one of their drugs has robust results. This is the same drug that caused the SRPT price to plummet 50% a few months ago.
Yeah man if we didn't have that market downturn in March, I think SRPT would be much higher than where it is now. I'm down like 95% on my options so I guess I'll just hold until the end and hope they announce some positive news in the next couple of weeks. Not sure if it's worth it to sell now after such a huge loss.
I realized I asked a silly question considering you explained what you were doing. I also noticed SRPT down over 50%, and how it has raised and fell in the past several times. You read charts well, you think it has the same potential? Forgive my ignorance
I already have \~$5k in $SRPT, $RKT, & $NET, but I am pretty sure I have to dump more into each at these levels. All 3 charts are fappable. Any other bulls out there missing an arm or leg because of these stocks but can't stop pouring more in?